Multiple Manufacturers

IXINITY

Manufacturer:

Multiple Manufacturers

Ixinity HCPCS:

J7213

HCPCS Code Descriptor:

Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.

Category:

J Code

Ixinity NDCs:

59137-0288-05, 70504-0287-05, 70504-0288-05, 59137-0287-05, 70504-0282-05, 70504-0283-05, 70504-0289-05, 59137-0283-05, 70504-0284-05, 59137-0282-05, 59137-0289-05, 59137-0284-05

Primary Type:

Hematology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Ixinity CPT Codes:

Potential CPT administration codes for Ixinity can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

59137-0287-05, 59137-0288-05

About Ixinity:

IXINITY is a medication manufactured by multiple manufacturers and aligned to the J Code: J7213. IXINITY is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J7213 Added Date:

July 1, 2023

J7213 Effective Date:

July 1, 2023

J7213 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ixinity billing and coding information.
Our team did not identify a source for Ixinity patient assistance information. Please reach out to our team if you feel that this is a mistake.
IXINITY prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for IXINITY. Please check back in a few weeks.